On July 16, 2025, Windtree Therapeutics, Inc. announced a private placement offering of approximately 60,000 shares of Series E Convertible Preferred Stock, raising up to $60 million, potentially increasing to $200 million, aimed at acquiring cryptocurrency and funding working capital.